1. Academic Validation
  2. QSAR studies on a number of pyrrolidin-2-one antiarrhythmic arylpiperazinyls

QSAR studies on a number of pyrrolidin-2-one antiarrhythmic arylpiperazinyls

  • Med Chem Res. 2012 Mar;21(3):373-381. doi: 10.1007/s00044-010-9540-x.
Alicja Nowaczyk Katarzyna Kulig
Abstract

The activity of a number of 1-[3-(4-arylpiperazin-1-yl)propyl]pyrrolidin-2-one antiarrhythmic (AA) agents was described using the quantitative structure-activity relationship model by applying it to 33 compounds. The molecular descriptors of the AA activity were obtained by quantum chemical calculations combined with molecular modeling calculations. The resulting model explains up to 91% of the variance and it was successfully validated by four tests (LOO, LMO, external test, and Y-scrambling test). Statistical analysis shows that the AA activity of the studied compounds depends mainly on the PCR and JGI4 descriptors. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00044-010-9540-x) contains supplementary material, which is available to authorized users.

Figures
Products